相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect ofSLCO1B1Polymorphisms on High-Dose Methotrexate Clearance in Children and Young Adults With Leukemia and Lymphoblastic Lymphoma
Rachael R. Schulte et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Genetic factors involved in delayed methotrexate elimination in children with acute lymphoblastic leukemia
Yu Cheng et al.
PEDIATRIC BLOOD & CANCER (2021)
Effect of Polymorphisms of ABCB1 and MTHFR on Methotrexate-Related Toxicities in Adults With Hematological Malignancies
Jian Han et al.
FRONTIERS IN ONCOLOGY (2021)
Systematic Review of Pharmacogenetic Factors That Influence High-Dose Methotrexate Pharmacokinetics in Pediatric Malignancies
Zachary L. Taylor et al.
CANCERS (2021)
Intravitreal Methotrexate
Fatemeh Abdi et al.
JOURNAL OF OPHTHALMIC & VISION RESEARCH (2021)
Serum Methotrexate Level and Side Effects of High Dose Methotrexate Infusion in Pediatric Patients with Acute Lymphoblastic Leukaemia (ALL)
Manjusha Sajith et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2020)
Adverse effects with intravenous methotrexate in children with acute lymphoblastic leukemia/lymphoma: a retrospective study
Piali Mandal et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2020)
Effects of germ me DHFR and FPGS variants on methotrexate metabolism and relapse of leukemia
Morten Tulstrup et al.
BLOOD (2020)
Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment
Nikola Kotur et al.
GENES (2020)
Molecular mechanism of action and pharmacokinetic properties of methotrexate
V Maksimovic et al.
MOLECULAR BIOLOGY REPORTS (2020)
The Role of ARID5B in Acute Lymphoblastic Leukemia and Beyond
Peiqi Wang et al.
FRONTIERS IN GENETICS (2020)
Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and Tandem TS Repeats Influence Pharmacokinetics, Acute Liver Toxicity, and Vomiting in Children With Acute Lymphoblastic Leukemia Treated With High Doses of Methotrexate
Magdalena Cwiklinska et al.
FRONTIERS IN PEDIATRICS (2020)
Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment
Sonja Pavlovic et al.
GENES (2019)
ARID5B gene polymorphisms and the risk of childhood acute lymphoblastic leukemia: a meta-analysis
Ju-Le Yang et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
Association Between the 5,10-MTHFR 677C > T and RFC1 80G > A Polymorphisms and Acute Lymphoblastic Leukemia
Yazmin Gomez-Gomez et al.
ARCHIVES OF MEDICAL RESEARCH (2019)
Polymorphisms of ABCG2 and its impact on clinical relevance
Wenji Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
DNA variants in DHFR gene and response to treatment in children with childhood B ALL: revisited in AIEOP-BFM protocol
Francesco Ceppi et al.
PHARMACOGENOMICS (2018)
Genetic markers in methotrexate treatments
Andrea Giletti et al.
PHARMACOGENOMICS JOURNAL (2018)
Pharmacogenomics of Methotrexate: Current Status and Future Outlook
Mengda Cao et al.
CURRENT DRUG METABOLISM (2018)
Application of CRS-PCR-RFLP to identify CYP1A1 gene polymorphism
Mingcui Ding et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2017)
SLCO1B1 rs4149056 genetic polymorphism predicting methotrexate toxicity in Chinese patients with non-Hodgkin lymphoma
Lin Yang et al.
PHARMACOGENOMICS (2017)
Association of ARID5B gene variants with acute lymphoblastic leukemia in Yemeni children
Boshra Al-absi et al.
TUMOR BIOLOGY (2017)
Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia
Shu-Guang Liu et al.
ONCOTARGET (2017)
Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach
Barbara Faganel Kotnik et al.
RADIOLOGY AND ONCOLOGY (2017)
Effect of thymidylate synthase (TYMS) gene polymorphisms with methotrexate treatment outcome in south Indian Tamil patients with rheumatoid arthritis
Niveditha Muralidharan et al.
CLINICAL RHEUMATOLOGY (2017)
Methotrexate-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses
Jared M. Campbell et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Preventing and Managing Toxicities of High-Dose Methotrexate
Scott C. Howard et al.
ONCOLOGIST (2016)
Association of 63/91 length polymorphism in the DHFR gene major promoter with toxicity of methotrexate in patients with rheumatoid arthritis
Biljana Jekic et al.
PHARMACOGENOMICS (2016)
MTHFR gene polymorphisms and methotrexate toxicity in adult patients with hematological malignancies: a meta-analysis
Ming Zhao et al.
PHARMACOGENOMICS (2016)
Effect of the Polymorphism of Folylpolyglutamate Synthetase on Treatment of High-Dose Methotrexate in Pediatric Patients with Acute Lymphocytic Leukemia
Zhen Huang et al.
MEDICAL SCIENCE MONITOR (2016)
Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcoma
Jeong A. Park et al.
BLOOD RESEARCH (2016)
Inherited genetic variation in childhood acute lymphoblastic leukemia
Takaya Moriyama et al.
BLOOD (2015)
Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia
Anna Wojtuszkiewicz et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis
Yogita Ghodke-Puranik et al.
PHARMACOGENOMICS (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Gene polymorphisms in the folate metabolism and their association with MTX-related adverse events in the treatment of ALL
Yang Chen et al.
TUMOR BIOLOGY (2015)
Homocysteine Metabolism Gene Polymorphisms (MTHFR C677T, MTHFR A1298C, MTR A2756G and MTRR A66G) Jointly Elevate the Risk of Folate Deficiency
Wen-Xing Li et al.
NUTRIENTS (2015)
Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia
M. A. H. den Hoed et al.
PHARMACOGENOMICS JOURNAL (2015)
Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia
Katalin Csordas et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Cancer Treatment and Survivorship Statistics, 2014
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Influence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemia
Shu-mei Wang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2
Marco Ferrari et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2014)
High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next?
Hala O. El Mesallamy et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Association between reduced folate carrier G80A polymorphism and methotrexate toxicity in childhood acute lymphoblastic leukemia: a meta-analysis
Hai-Rong He et al.
LEUKEMIA & LYMPHOMA (2014)
The protective role of MTR A2756G polymorphisms in childhood acute lymphoblastic leukemia remains inconclusive
Su-yi Li et al.
LEUKEMIA & LYMPHOMA (2014)
Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies
Sujatha Suthandiram et al.
PHARMACOGENOMICS (2014)
Novel Insights Into Etiologies of Leukemia: A HuGE Review and Meta-Analysis of CYP1A1 Polymorphisms and Leukemia Risk
Fujun Han et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Genome-wide study of methotrexate clearance replicates SLCO1B1
Laura B. Ramsey et al.
BLOOD (2013)
Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia
Susanne Radtke et al.
BLOOD (2013)
FPGS rs1544105 polymorphism is associated with treatment outcome in pediatric B-cell precursor acute lymphoblastic leukemia
Shu-Guang Liu et al.
CANCER CELL INTERNATIONAL (2013)
Intron 3 of the ARID5B gene: a hot spot for acute lymphoblastic leukemia susceptibility
Angela Gutierrez-Camino et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia
E. Lopez-Lopez et al.
PHARMACOGENOMICS JOURNAL (2013)
High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients
Laila Holmboe et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE)
Alicia Amigou et al.
CANCER CAUSES & CONTROL (2012)
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue
Patrizia Chiusolo et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Evidence from 2013 cases and 2903 controls
Wenlei Zhuo et al.
GENE (2012)
Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition
Laura B. Ramsey et al.
GENOME RESEARCH (2012)
Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: evidence from 35 case-control studies
Dong Han et al.
MOLECULAR BIOLOGY REPORTS (2012)
Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia
Nina Erculj et al.
LEUKEMIA & LYMPHOMA (2012)
Association of MTHFR, MTR, MTRR, RFC1, and DHFR Gene Polymorphisms with Susceptibility to Sporadic Colon Cancer
Mladen Jokic et al.
DNA AND CELL BIOLOGY (2011)
Prognostic value of the multidrug resistance transporter ABCG2 gene polymorphisms in Chinese patients with de novo acute leukaemia
Fang Wang et al.
EUROPEAN JOURNAL OF CANCER (2011)
Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma
Barbara Faganel Kotnik et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Polymorphisms of the SLCO1B1 Gene Predict Methotrexate-Related Toxicity in Childhood Acute Lymphoblastic Leukemia
Elixabet Lopez-Lopez et al.
PEDIATRIC BLOOD & CANCER (2011)
PharmGKB summary: methotrexate pathway
Torben S. Mikkelsen et al.
PHARMACOGENETICS AND GENOMICS (2011)
Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
Mikko Niemi et al.
PHARMACOLOGICAL REVIEWS (2011)
The association of reduced folate carrier 80G>A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy number
Jannie Gregers et al.
BLOOD (2010)
Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia
Jasmine Healy et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
ABCG2: A perspective
Robert W. Robey et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Advances in individual prediction of methotrexate toxicity: a review
Kjeld Schmiegelow
BRITISH JOURNAL OF HAEMATOLOGY (2009)
C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation
Elena De Mattia et al.
EUROPEAN JOURNAL OF CANCER (2009)
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival
Alessia Ongaro et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
The MTHFD1 p.Arg653Gln Variant Alters Enzyme Function and Increases Risk for Congenital Heart Defects
Karen E. Christensen et al.
HUMAN MUTATION (2009)
Evidence for increased cytochrome P450 1A1 expression in blood lymphocytes of lung cancer patients
Parag P. Shah et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2009)
MTHFD1 gene:: role in disease susceptibility and pharmacogenetics
Maja Krajinovici
PHARMACOGENOMICS (2008)
Identification of a novel single nucleotide polymorphism in the first tandem repeat sequence of the thymidylate synthase 2R allele
Lisa F. Lincz et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in metho trexate-treated rheumatoid arthritis patients
R. J. H. M. van der Straaten et al.
PHARMACOGENOMICS (2007)
The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis
Yehuda G. Assaraf
DRUG RESISTANCE UPDATES (2006)
Understanding and managing methotrexate nephrotoxicity
Brigitte C. Widemann et al.
ONCOLOGIST (2006)
Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis
T Dervieux et al.
ARTHRITIS AND RHEUMATISM (2004)
Disparate mechanisms of antifolate resistance provoked by methotrexate and its metabolite 7-hydroxymethotrexate in leukemia cells: implications for efficacy of methotrexate therapy
K Fotoohi et al.
BLOOD (2004)
Origins of chromosome translocations in childhood leukaemia
MF Greaves et al.
NATURE REVIEWS CANCER (2003)
Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer
J Chen et al.
PHARMACOGENETICS (2002)
分享论文
